Lung Cancer Online
Home Care Support Info Treatment Effects Tests Surviving Sites MedLit

 home > treatment > agents & regimens > vinorelbine (Navelbine)

Vinorelbine (Navelbine) : Burroughs Wellcome : Chemotherapeutic agent

Vinorelbine (Navelbine) Clinical Research
Vinorelbine (Navelbine) Side Effects
Vinorelbine (Navelbine) & Cisplatin
Paclitaxel (Taxol) & Vinorelbine (Navelbine)
Gemcitabine (Gemzar) & Vinorelbine (Navelbine)

Clinical Research

Non-Small Cell Lung Cancer: A Study of Long-Term Survival After Vinorelbine (The Oncologist)
Julien, S., et al.
v.5, no.2 The Oncologist (April 2000): 115-119
Reports the results of a study that showed a percentage of patients with inoperable NSCLC can experience prolonged survival after treatment with single agent Navelbine.

Vinorelbine (Navelbine) - Recent MEDLINE Abstracts (PubMed)

Vinorelbine - Clinical Trials (

Side Effects


Vinorelbine (Navelbine) & Cisplatin

Phase II Trial of Docetaxel and Vinorelbine in Patients with Advanced Non-Small Cell Lung Cancer (Journal of Clinical Oncology)
Abstract of a Journal of Clinical Oncology article (March 2000 issue) reporting the results of a study that found docetaxel and vinorelbine, both given every 2 weeks, is a highly active combination for the treatment of advanced NSCLC. [3/00]

Vinorelbine and Cisplatin - Recent MEDLINE Abstracts (PubMed)


Feedback / Queries Disclaimer Advocacy - You Can Help

Copyright © 1999-2006, Lung Cancer Online Foundation
Last modified: 26-Apr-2011
Karen Parles, MLS Editor